Candriam Luxembourg S.C.A. »

Monte Rosa Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2023-12-31 $763k 135k 5.65
2023-09-30 $647k 135k 4.79
2023-06-30 $925k 135k 6.85

More positions owned by Candriam Luxembourg S.C.A.

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Visa Com Cl A (V)
Gilead Sciences (GILD)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
Procter & Gamble Company (PG)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
Aisling Capital Management
Alphabet
Citadel Advisors
Casdin Capital
Caption Management
Charles Schwab Investment Management
TD Asset Management
Candriam Luxembourg S.C.A.
Bank of New York Mellon
Bank of America Corporation

View all funds holding Monte Rosa Therapeutics